• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini-review with a representative case report.

作者信息

Venturini M, Zanca A, Venturuzzo A, Filippini M, Frassi M, Tincani A, Calzavara-Pinton P G

机构信息

Dermatology Department, University of Brescia, ASST Spedali Civili Hospital, Brescia, Italy.

Rheumatology and Clinical Immunology Unit, University of Brescia, ASST Spedali Civili Hospital, Brescia, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e110-e112. doi: 10.1111/jdv.16035. Epub 2019 Nov 14.

DOI:10.1111/jdv.16035
PMID:31667904
Abstract
摘要

相似文献

1
Secukinumab for patients with plaque psoriasis affected by multiple sclerosis: a mini-review with a representative case report.司库奇尤单抗治疗合并多发性硬化症的斑块状银屑病患者：一篇包含典型病例报告的小型综述
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e110-e112. doi: 10.1111/jdv.16035. Epub 2019 Nov 14.
2
A case of psoriasis and multiple sclerosis succesfully treated with concomitant fingolimod and secukinumab.一例银屑病和多发性硬化症患者同时使用芬戈莫德和司库奇尤单抗成功治愈。
Australas J Dermatol. 2023 Feb;64(1):e100-e102. doi: 10.1111/ajd.13983. Epub 2023 Jan 22.
3
Secukinumab: a potential safe option in psoriasis patients affected by multiple sclerosis?司库奇尤单抗：对患有多发性硬化症的银屑病患者而言是一个潜在的安全选择？
Int J Dermatol. 2020 Aug;59(8):e308-e309. doi: 10.1111/ijd.14902. Epub 2020 May 2.
4
Psoriasis during natalizumab treatment for multiple sclerosis.多发性硬化症患者在接受那他珠单抗治疗期间出现银屑病。
J Neurol. 2012 Dec;259(12):2758-60. doi: 10.1007/s00415-012-6713-1. Epub 2012 Oct 25.
5
Ixekizumab for Patients with Plaque Psoriasis Affected by Multiple Sclerosis: Case report.依奇珠单抗治疗多发性硬化斑块型银屑病患者：病例报告。
Sultan Qaboos Univ Med J. 2021 Aug;21(3):488-490. doi: 10.18295/squmj.4.2021.021. Epub 2021 Aug 29.
6
Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.乌司奴单抗成功治疗多发性硬化症患者的银屑病。
Dermatol Online J. 2015 Jul 15;21(7):13030/qt3bs971cr.
7
Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis.司库奇尤单抗与富马酸二甲酯联合治疗一名银屑病患者及近期诊断为多发性硬化症的病例
Dermatol Ther. 2020 Nov;33(6):e13943. doi: 10.1111/dth.13943. Epub 2020 Jul 14.
8
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report.一名银屑病患者使用司库奇尤单抗后出现药物性勃起功能障碍，换用依奇珠单抗后问题解决：一例报告
Curr Drug Saf. 2020;15(1):69-72. doi: 10.2174/1574886314666190726155147.
9
Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies.在使用司库奇尤单抗治疗无效的斑块状银屑病患者中换用依奇珠单抗的疗效与安全性：一项关于白细胞介素17A拮抗剂疗法的多中心回顾性研究
J Am Acad Dermatol. 2018 Jul;79(1):155-157. doi: 10.1016/j.jaad.2018.01.003. Epub 2018 Jan 4.
10
A prospective multicenter study assessing effectiveness and safety of secukinumab in a real-life setting in 158 patients.一项评估司库奇尤单抗在 158 例患者真实环境中的有效性和安全性的前瞻性多中心研究。
J Am Acad Dermatol. 2019 Aug;81(2):427-432. doi: 10.1016/j.jaad.2019.02.062. Epub 2019 Mar 11.

引用本文的文献

1
Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience.评估司库奇尤单抗治疗合并症患者的中轴型脊柱关节炎和银屑病关节炎：多中心真实世界经验
J Clin Med. 2025 Jul 22;14(15):5181. doi: 10.3390/jcm14155181.
2
Safety and efficacy of IL-17 inhibitors in patients with comorbid multiple sclerosis/multiple Sclerosis-like syndrome: a systematic review.白细胞介素-17抑制剂在合并多发性硬化症/多发性硬化样综合征患者中的安全性和有效性：一项系统评价。
Rheumatol Int. 2025 Jun 3;45(6):147. doi: 10.1007/s00296-025-05902-7.
3
Successful Guselkumab Treatment in a Patient with Comorbid Psoriasis and Amyotrophic Lateral Sclerosis: A Case Study and Literature Review.
古塞库单抗成功治疗合并银屑病和肌萎缩侧索硬化症的患者：病例研究与文献综述
Clin Cosmet Investig Dermatol. 2025 Mar 27;18:735-741. doi: 10.2147/CCID.S505143. eCollection 2025.
4
Risk of multiple sclerosis in patients with psoriasis receiving anti-IL-17 agents: A case-based review.抗白细胞介素-17 药物治疗银屑病患者多发性硬化症的风险：基于病例的综述。
J Dermatol. 2024 Jun;51(6):844-848. doi: 10.1111/1346-8138.17143. Epub 2024 Feb 12.
5
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review.伴有银屑病关节炎的患者使用阿达木单抗治疗后的脱髓鞘疾病（多发性硬化症）：基于病例的综述。
Rheumatol Int. 2021 Dec;41(12):2233-2239. doi: 10.1007/s00296-021-04995-0. Epub 2021 Sep 23.
6
Ixekizumab for Patients with Plaque Psoriasis Affected by Multiple Sclerosis: Case report.依奇珠单抗治疗多发性硬化斑块型银屑病患者：病例报告。
Sultan Qaboos Univ Med J. 2021 Aug;21(3):488-490. doi: 10.18295/squmj.4.2021.021. Epub 2021 Aug 29.
7
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.多发性硬化症合并自身免疫性疾病患者的治疗方法。
Ther Adv Neurol Disord. 2021 Aug 23;14:17562864211035542. doi: 10.1177/17562864211035542. eCollection 2021.
8
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.伴有合并症和特殊人群的中重度银屑病的生物治疗算法：综述。
Am J Clin Dermatol. 2021 Jul;22(4):425-442. doi: 10.1007/s40257-021-00603-w. Epub 2021 Apr 16.
9
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2).银屑病合并炎症性、神经性、感染性或恶性疾病时全身治疗的实用建议（BETA-PSO：比利时银屑病循证治疗建议；第2部分）
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1914-1923. doi: 10.1111/jdv.16683. Epub 2020 Aug 13.